Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against BlueBird Bio, Inc. (NASDAQ: BLUE)

Federman & Sherwood announces that on March 28, 2024, a class action lawsuit was filed in the United States District Court for the District of Massachusetts against BlueBird Bio, Inc. (NASDAQ: BLUE). The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a series of material or false misrepresentations to the market with had the effect of artificially inflating the market price during the Class Period, which is April 24, 2023, through December 8, 2023.

Plaintiff seeks to recover damages on behalf of all BlueBird Bio, Inc. shareholders who purchased common stock during the Class Period and are therefore a member of the Class as described above. You may move the Court no later than Tuesday, May 28, 2024, to serve as a lead plaintiff for the entire Class. However, to do so, you must meet certain legal requirements pursuant to the Private Securities Litigation Reform Act of 1995.

If you wish to discuss this action, obtain further information, and/or participate in this litigation, please contact Tiffany Peintner either by email at trp@federmanlaw.com or visit our firm’s website www.federmanlaw.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240412296465/en/